BCAL Diagnostics Limited (AU:BDX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jayne Shaw, a director at BCAL Diagnostics Limited, has increased her stake in the company by acquiring 480,748 ordinary shares through an on-market purchase, valued at $50,478. This move signifies her growing confidence in BCAL Diagnostics’ future prospects, drawing attention from investors eager to follow insider trading activities for potential market insights.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.